Indefinite Delivery Contract 36C24925D0015

Award Date 10/1/24
Last Date to Order 9/30/29
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The key points are: This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs, Veterans Integrated Service Network 9 (VISN 9) to Roche Diagnostics Corporation, a large business manufacturer and distributor of in-vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $991,073.55 IDC has a period of performance through September 30, 2024 and provides a vehicle for VISN 9 to acquire reagents, test kits, test sets, and...
This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA), through its Veterans Integrated Service Network 17, to Roche Diagnostics Corporation for the provision of Roche Ventana reagents and consumables. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, has provided critical care analyzers, reagents, test kits, and associated laboratory equipment and supplies to various federal agencies, including the VA, Department of...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $415,022.25 contract has a period of performance from September 1, 2024 to August 31, 2027 and is for the provision of Roche Diagnostics' COVID-19 reagents and Cobas supplies to the VA. Roche Diagnostics has been awarded numerous...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, for the procurement of Ventana immunohistochemical reagents and associated laboratory equipment, supplies, and services. This single-award IDC has a potential value of $2,442,399.60 over a 5-year ordering period from March 2024 to March 2029. Under this IDC, the VA VHA Network Contracting Office 17...
The federal contract IDV award was issued by the Department of Veterans Affairs Veterans Health Administration (VA-VHA) Veterans Integrated Service Network 9 to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory instruments. The $733,089.60 single-award IDC has an ultimate completion date of July 31, 2024 and does not utilize any set-aside designations. Under this IDC, Roche Diagnostics has been awarded multiple firm fixed price...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a series of firm fixed price delivery orders under an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The total ceiling value of the IDC is $2,403,690.00, with the most recent delivery order valued at $480,738.00 and a performance period ending on September 30, 2025. The delivery orders are...
The U.S. Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at up to $15,466,932.92, is for the rental of Molecular Diagnostics Analyzers and associated reagents to support the VA's laboratory testing capabilities across its healthcare facilities. Two delivery orders have been issued...
This indefinite delivery contract was awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at a ceiling of $389,666.38, provides the VA with a 5-year ordering period to acquire Roche's clinical chemistry analyzers, reagents, and testing services to support immunochemistry, hematology, molecular diagnostics,...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 6 has awarded a single-award Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and related laboratory equipment and supplies. The IDC, valued at up to $3,272,813.29, has a period of performance through September 30, 2025 and allows the agency to issue delivery orders for Roche's products and services on an as-needed basis. Under this IDC, the VA has...
This federal contract IDV award by the Department of Veterans Affairs' Veterans Integrated Service Network 9 to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, provides for the delivery of reagents over a period of 3 years from October 1, 2024 to September 30, 2027. The contract, valued at $225,409.54, is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Roche Diagnostics is a manufacturer and distributor of in vitro...
  • 36C24925D0015
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) Network Contracting Office 9 to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The contract, valued at $470,851.70, is for the delivery of Roche HE600 reagents over a period ending on September 30, 2029. This delivery order is part of a larger IDC held by Roche to supply chemistry reagents to VA and military treatment facilities across a five-year ordering period.

The original solicitation was a sources sought notice issued by the VA to identify qualified parties interested in providing a five-year, firm-fixed-price contract for the delivery of reagents compatible with the Ventana HE 600 analyzers currently owned by the Louisville VA Medical Center. The procurement was not associated with any set-aside programs. The notice requested capability information from interested vendors, including business size and type, ability to meet the requirement, and potential joint venture plans. Based on the responses, the VA will determine the appropriate procurement method, which could include setting the requirement aside for service-disabled veteran-owned small businesses, veteran-owned small businesses, or small businesses, or conducting a full and open competition.

Generated 10/16/24, 9:07 AM